--2025/Q4-- / 1.042T--
Jan 30, 20252025/Q3-- / 1.132T--
Oct 31, 20242025/Q21.176T / 1.079T--
Jul 31, 20242025/Q11.208T / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
US Stock MarketDetailed Quotes
TAK Takeda Pharmaceutical
- 13.100
- +0.090+0.69%
Close Dec 20 16:00 ET
- 13.100
- 0.0000.00%
Post 20:01 ET
41.68BMarket Cap22.66P/E (TTM)
13.190High13.020Low1.85MVolume13.040Open13.010Pre Close24.28MTurnover0.06%Turnover Ratio45.17P/E (Static)3.18BShares14.74252wk High0.95P/B39.89BFloat Cap12.29352wk Low0.63Dividend TTM3.05BShs Float19.900Historical High4.82%Div YieldTTM1.31%Amplitude11.308Historical Low13.131Avg Price1Lot Size
Takeda Pharmaceutical Key Stats
Takeda Pharmaceutical Q2 2025 Earnings Date
Currency：JPYOct 31, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 1.08T | 1.18T | +96.82B |
| Beat Est. | +3.46% | +12.75% | +8.97% |
| EPS | -- | 28.59 | -- |
+286.34% |
Analyst Rating
Dec 22, 2024
Takeda Pharmaceutical Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Takeda Pharmaceutical Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
